MARKET

ADILW

Adial Pharmaceuticals
ADILW
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-0.9153
-
0.0178
-
ADIAL PHARMACEUTICALS ANNOUNCES A WARRANT INDUCEMENT TRANSACTION FOR APPROXIMATELY $2.86 MILLION IN GROSS PROCEEDS
Reuters · 11/26 13:00
Adial Pharmaceuticals Q3 net loss beats expectations on lower R&D expenses 
Reuters · 11/14 13:38
Adial Pharmaceuticals reports Q3 net loss of $1.8 million
Reuters · 11/14 13:36
ADIAL PHARMACEUTICALS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Reuters · 11/14 13:30
ADIAL PHARMACEUTICALS: IMPLEMENTING FDA'S RECOMMENDATIONS BASED ON EOP2 MEETING, TO ADVANCE AD04 TOWARD PHASE 3 DEVELOPMENT
Reuters · 11/14 13:30
ADIAL PHARMACEUTICALS INC <ADIL.O>: MAXIM GROUP RAISES TO BUY FROM HOLD
Reuters · 09/30 12:04
U.S. RESEARCH ROUNDUP-Electronic Arts, Kala Bio, Semtech
Reuters · 09/30 07:01
BUZZ-Adial rises on positive FDA feedback for its late-stage alcohol disorder drug study
Reuters · 09/16 12:41
More

Webull offers Adial Pharmaceuticals stock information, including NASDAQ: ADILW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADILW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADILW stock methods without spending real money on the virtual paper trading platform.